Estée Lauder’s Turnaround Gains Momentum, but Execution Risk Remains High

The core principle of value investing is that a low price is not a bargain if the underlying business is deteriorating. This is the fallacy that investors must avoid when confronted with deeply beaten-down stocks. A stock trading at a 5-year low may appear cheap on a price-to-earnings ratio, but if its competitive moat is eroding and its intrinsic value is falling, that discount is a warning sign, not an invitation. As the podcast notes, a falling stock price is not the only criteria for finding a value stock. The real test is whether the company still has solid fundamentals and a durable business model.

This distinction is critical for understanding why Estée Lauder and Helen of Troy are not compelling value investments. Their deep price declines reflect structural business problems, not temporary market sentiment. For Helen of Troy, the evidence points to fundamental erosion. The company has seen substantially decreasing revenue across both of its core segments, with large declines even after accounting for the post-pandemic normalization of sales. This revenue pressure, coupled with significant goodwill write-offs, has squeezed profits and led to a dramatic stock collapse. The risk here is a classic value trap, where the stock's decline is due to fundamental issues like revenue erosion, not a mispricing.

For Estée Lauder, the setup is similar. While the company has a strong brand portfolio, its recent trajectory shows a business under pressure. The stock's plunge to 5-year lows is accompanied by a history of earnings declines, with analysts expecting a sharp drop in 2025 before a projected rebound. The key for a value investor is to focus on the durability of the business model, not just the P/E ratio. As one investor's method highlights, a margin of safety requires looking beyond the headline price and assessing the business's ability to generate cash. In this light, a stock trading at a discount is only a potential bargain if its competitive moat and intrinsic value remain intact. When those foundations are crumbling, the low price is a signal to be cautious, not to buy.

Case Study 1: Helen of Troy – A Business in Structural Decline

The story of Helen of Troy is a textbook example of a stock price collapse signaling permanent damage to a business's economic moat. The company's stock is down 60% year-to-date, a brutal decline that reflects fundamental erosion, not a temporary market overreaction. The core issue is a structural loss of pricing power and consumer demand across both of its segments. Even after accounting for the post-pandemic normalization of sales, the company has seen substantially decreasing revenue, with both the Hone & Outdoor and Health & Beauty segments reporting large declines of over 10% in its latest quarter. This revenue pressure has squeezed profits and led to a dramatic stock collapse.

Management's own actions confirm the severity of the situation. The company has taken a staggering over $400 million in goodwill and intangible write-offs. This is not a minor accounting adjustment; it is a formal admission that the value of its past acquisitions and brand portfolios has permanently diminished. It is a classic sign of a business model under stress, where the promised synergies and growth have failed to materialize. Furthermore, the company has been forced to revise its guidance lower, indicating that the problems extend beyond a single quarter and into the near-term outlook.

Analysts' fair value estimates, while still above the current price, reveal a market struggling to see a clear path forward. The Simply Wall St fair value estimate holds at US$28.00 per share, but analyst price targets cluster closer to $22. This gap is telling. It reflects a balance between better-than-expected execution in a few brands like OXO and Osprey, and deep concerns over broader portfolio pressure and profitability. The consensus is not bullish on a turnaround; it is cautious, waiting to see if the company can stabilize its core segments. For a value investor, the key question is whether the current price offers a sufficient margin of safety given this structural decline. The evidence suggests the moat is narrowing, and the low price is a warning sign of permanent damage, not a temporary mispricing.

Case Study 2: Estée Lauder – A Turnaround Story with High Execution Risk

The story of Estée Lauder presents a more nuanced picture than Helen of Troy. Here, a company is actively executing a turnaround plan, delivering improved quarterly results and raising its full-year outlook. The latest quarter saw sales rise to $4.2 billion and net income reach $162 million, a dramatic reversal from the prior year's losses. Management has reaffirmed its dividend and now forecasts 3%–5% reported sales growth and EPS of $0.98–$1.22 for the full year. This progress, driven by stronger performance in skincare and fragrance and better margins, signals that the company's 'Beauty Reimagined' plan is beginning to translate into healthier earnings.

Yet for a value investor, the key question is whether this improved outlook fully offsets the long-term challenges that drove the stock's prior decline. The turnaround is still in its early stages. The company's recent struggles were rooted in significant headwinds, particularly in travel retail and China, which remain concentration risks. As one analysis notes, the current investment thesis requires believing that these pressures are now "manageable" while the company rebuilds margins. The raised guidance supports that narrative, but it does not remove the fundamental vulnerability.

This sets up a classic value dilemma. The stock's plunge to 5-year lows created a lower price, which can be appealing. But as the principle of the beaten-down fallacy warns, a low price is only a bargain if the business model's intrinsic value is intact. Estée Lauder's case is that the model is being rebuilt, but the foundation-its exposure to volatile Asian markets and travel retail-has not yet been fully resolved. The investor must weigh the appeal of a lower price against the risk that any setback in these areas could quickly reintroduce earnings volatility, undermining the turnaround.

The bottom line is one of high execution risk. The company is showing clear progress, but the path to restoring its competitive moat and compounding value over the long cycle is not yet proven. For a disciplined investor, the margin of safety here depends less on the current P/E and more on the durability of the recovery. Until the company demonstrates it can grow consistently without being hostage to a few key markets, the low price remains a signal of a business in transition, not a clear value trap.

Valuation and Margin of Safety: The Absence of a Cushion

For a disciplined investor, a low price is only the starting point. The real question is whether that price offers a sufficient margin of safety-a buffer against error and uncertainty. As one investor's method illustrates, a margin of safety requires a significant discount to a conservative estimate of intrinsic value. If the enterprise value is less than 20 times that adjusted number, I consider it a buy. This framework is absent for both Estée Lauder and Helen of Troy. Their current valuations do not appear to provide the wide enough cushion to justify the risks inherent in their business models.

The core of a true value investment, however, is not just a low price, but a business that is compounding at a high rate. The Morningstar list of "best value stocks to buy for the long term" explicitly targets companies with wide Morningstar Economic Moat Ratings and predictable cash flows. This is the hallmark of a durable business that can generate increasing value over time. For Helen of Troy, the narrative is one of structural decline, with revenue erosion and goodwill write-offs indicating a narrowing moat. For Estée Lauder, while a turnaround is underway, the path to compounding remains uncertain, hinging on managing volatile regional exposures. In neither case is there a clear, high-rate compounding story that would make a low price a compelling bargain.

This leads to the final, critical question: where should capital be deployed? The investor must consider whether the potential returns from these beaten-down stocks justify the capital allocation, especially when better opportunities exist elsewhere. The Morningstar list highlights companies with wide moats and predictable cash flows as the ideal long-term holdings. In contrast, both Estée Lauder and Helen of Troy are in the midst of business transitions or declines, where the outcome is far from certain. The capital required to build a position in these companies would be better used to acquire a stake in a business with a wider economic moat and a clearer, more predictable path to compounding value. As the principle of averaging down warns, buying more of a stock simply because it has fallen is a strategy, not a coincidence. For a value investor, the decision should be based on the quality of the business, not the price of the shares.